We are investigating new techniques for using laser therapy in the prevention of the sight threatening consequences of diabetic retinopathy and retinal ischemia. Our approach is to use better targeted therapy and the minimum level of laser treatment required to produce the therapeutic benefit.
This involves research into the interaction between different wavelength lasers and the retinal tissue, as well as the use of energy modulation of the laser to confine the laser therapy to specific cell types.
